Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-154
Closed -$2.94K 618
2025
Q1
$2.94K Sell
154
-1,132
-88% -$24.8K ﹤0.01% 696
2024
Q4
$30.7K Sell
1,286
-13
-1% -$363 ﹤0.01% 512
2024
Q3
$36.4K Hold
1,299
﹤0.01% 502
2024
Q2
$34K Hold
1,299
﹤0.01% 500
2024
Q1
$28.4K Hold
1,299
﹤0.01% 529
2023
Q4
$30.2K Hold
1,299
﹤0.01% 492
2023
Q3
$25.6K Hold
1,299
﹤0.01% 499
2023
Q2
$29.4K Hold
1,299
﹤0.01% 495
2023
Q1
$25.5K Sell
1,299
-10
-0.8% -$192 ﹤0.01% 524
2022
Q4
$22.5K Buy
+1,309
New +$23.2K ﹤0.01% 532

Other funds holding RXO

Washington Trust's RXO Position: Q2 2025 in Review

Washington Trust sold out of RXO (RXO) in Q2 2025, closing a stake of 154 shares — an estimated $2.94K sold.

Washington Trust first reported a position in RXO in Q4 2022 and held it in 10 quarters. The position peaked at $36.4K in Q3 2024. 268 funds tracked by Wall St. Rank hold RXO as of Q2 2025.

  • Washington Trust reported no remaining RXO position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 154 RXO shares in Q2 2025, an estimated $2.94K.
  • Washington Trust first reported a position in RXO in Q4 2022 and held it in 10 quarters.
  • Washington Trust's RXO position peaked at $36.4K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held RXO as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.